HomeMost PopularAnalysts See 12% Gains Ahead For The Holdings of IVE

Analysts See 12% Gains Ahead For The Holdings of IVE

Daily Market Recaps (no fluff)

always free

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares S&P 500 Value ETF (Symbol: IVE), we found that the implied analyst target price for the ETF based upon its underlying holdings is $201.42 per unit.

With IVE trading at a recent price near $180.33 per unit, that means that analysts see 11.70% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of IVE’s underlying holdings with notable upside to their analyst target prices are Cardinal Health, Inc. (Symbol: CAH), Lowe’s Companies Inc (Symbol: LOW), and AbbVie Inc (Symbol: ABBV). Although CAH has traded at a recent price of $96.14/share, the average analyst target is 17.54% higher at $113.00/share. Similarly, LOW has 17.18% upside from the recent share price of $214.27 if the average analyst target price of $251.07/share is reached, and analysts on average are expecting ABBV to reach a target price of $177.52/share, which is 14.69% above the recent price of $154.79. Below is a twelve month price history chart comparing the stock performance of CAH, LOW, and ABBV:

CAH, LOW, and ABBV Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
iShares S&P 500 Value ETF IVE $180.33 $201.42 11.70%
Cardinal Health, Inc. CAH $96.14 $113.00 17.54%
Lowe’s Companies Inc LOW $214.27 $251.07 17.18%
AbbVie Inc ABBV $154.79 $177.52 14.69%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock’s trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

nslideshow 10 ETFs With Most Upside To Analyst Targets »

Also see:

• Entertainment Dividend Stocks
• SMPL market cap history
• SDEM Options Chain

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Do you want a daily market summary with no fluff?

Simple Straightforward Daily Stock Market Recaps Sent for free,every single trading day: Read Now

Explore More

Simple Straightforward Daily Stock Market Recaps

Get institutional-level analysis to take your trading to the next level, sign up for free and become apart of the community.